Peptidream logo

Peptidream

Asia, Tokyo, Japan, Tokyo

Description

Peptidream is a biopharmaceutical company that offers a peptide drug discovery ecosystem through collaborations.

Investor Profile

Peptidream has backed more than 4 startups, with 2 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Corporate Round rounds (top funding stages).
  • Majority of deals are located in Japan, United States.
  • Strong thematic focus on Health Care, Medical, Pharmaceutical.

Stage Focus

  • Series B (75%)
  • Corporate Round (25%)

Country Focus

  • Japan (75%)
  • United States (25%)

Industry Focus

  • Health Care
  • Medical
  • Pharmaceutical
  • Health Diagnostics
  • Oncology
  • Business Information Systems
  • Document Management
  • Information Services
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Peptidream frequently co-invest with?

Hamari Chemicals
Asia, Osaka, Japan, Osaka
Co-Investments: 1
Chiyoda Corporation
Asia, Kanagawa, Japan, Yokohama
Co-Investments: 1
Kishida Japan
Asia, Osaka, Japan, Osaka
Co-Investments: 1
Co-Investments: 1
Axil Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
JIC Venture Growth Investments
Asia, Tokyo, Japan, Marunouchi
Co-Investments: 2
Microwave Chemical
Asia, Osaka, Japan, Suita
Co-Investments: 1
Biohaven Pharmaceutical
North America, Connecticut, United States, New Haven
Co-Investments: 1
DBJ Capital
Asia, Tokyo, Japan, Otemachi
Co-Investments: 2
AMED
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

What are some of recent deals done by Peptidream?

Linqmed

Chiba, Chiba, Japan

Linqmed is a pharmaceutical company specializing in the research and development of radiopharmaceuticals for cancer treatment.

Health CareHealth DiagnosticsMedicalOncologyPharmaceutical
Series BApr 9, 2025
Amount Raised: $15,932,011
Linqmed

Chiba, Chiba, Japan

Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.

Health CareHealth DiagnosticsMedicalOncologyPharmaceutical
Series BJan 10, 2025
Amount Raised: $9,512,632
Kleo

New Haven, Connecticut, United States

Kleo is developing two types of small molecules to treat cancer, infectious diseases, and a broad range of indications

Health CareMedicalPharmaceutical
Series BNov 14, 2018
Amount Raised: $21,000,000
PeptiStar

Settsu, Osaka, Japan

PeptiStar continually strives to develop novel manufacturing technologies to address needs in every stage of the peptide value chain.

Business Information SystemsDocument ManagementInformation ServicesManufacturing
Corporate RoundApr 18, 2018
Amount Raised: $186,286,291